BioNTech SE (BNTX) Amortization (2018 - 2023)

BioNTech SE has disclosed Amortization across 5 years of filings, most recently posting $21.6 billion for Q3 2023.

• Amortization for Q3 2023 came in at $21.6 billion, up 16.79% year-over-year; the trailing twelve-month figure through Sep 2023 was $83.6 billion (up 53.12% YoY), and the FY2019 annual result was $198323.3, up 247.85% from the prior year.
• Amortization came in at $21.6 billion for Q3 2023 at BioNTech SE, roughly flat from $21.7 billion in the prior quarter.
• In the past five years, Amortization ranged from a high of $21.8 billion in Q1 2023 to a low of -$133.7 million in Q4 2019.
• The 4-year median for Amortization is $245.3 million (2020), against an average of $9.2 billion.
• Across the five-year window, Amortization tumbled 150.57% in 2019 and soared 632.42% in 2020, its largest moves.
• BioNTech SE's Amortization stood at -$133.7 million in 2019, then surged by 283.52% to $245.3 million in 2020, then surged by 7448.2% to $18.5 billion in 2022, then gained by 16.79% to $21.6 billion in 2023.
• The last three Amortization figures came in at $21.6 billion (Q3 2023), $21.7 billion (Q2 2023), and $21.8 billion (Q1 2023), per Business Quant data.